Essential tremor: Treatment options

Current Treatment Options in Neurology

Volumn 8, Issue 3, 2006, Pages 256-267

  Ondo, William G ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETAZOLAMIDE; ALCOHOL; ALPRAZOLAM; AROTINOLOL; ATENOLOL; BARBITURIC ACID DERIVATIVE; BENZODIAZEPINE DERIVATIVE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BOTULINUM TOXIN A; CLONAZEPAM; CLONIDINE; CLOZAPINE; ETIRACETAM; FLUNARIZINE; GABAPENTIN; METOPROLOL; NADOLOL; NICARDIPINE; NIMODIPINE; OCTANOL; OXYBATE SODIUM; PHENOBARBITAL; PINDOLOL; PRACTOLOL; PRIMIDONE; PROPRANOLOL; SOTALOL; TOPIRAMATE; UNINDEXED DRUG; ZONISAMIDE;

ACUTE DISEASE; AGRANULOCYTOSIS; ATAXIA; ATTENTION DISTURBANCE; BLURRED VISION; BODY WEIGHT DISORDER; BRAIN DEPTH STIMULATION; CENTRAL NERVOUS SYSTEM DISEASE; CLINICAL TRIAL; CONFUSION; DEPRESSION; DIARRHEA; DISEASE EXACERBATION; DISEASE SEVERITY; DIZZINESS; DRUG EFFICACY; DRUG ERUPTION; DRUG HALF LIFE; DRUG MECHANISM; DRUG PENETRATION; DRUG TOLERABILITY; ESSENTIAL TREMOR; EXTRAPYRAMIDAL SYMPTOM; FATIGUE; HUMAN; HYPOTENSION; IMPOTENCE; JOINT FUNCTION; MEDICAL DECISION MAKING; MENTAL CONCENTRATION; MENTAL DISEASE; NAUSEA; NEPHROLITHIASIS; NERVOUSNESS; NEUROTOXICITY; PARESTHESIA; REVIEW; RISK BENEFIT ANALYSIS; SEDATION; SIDE EFFECT; SOMNOLENCE; SURGICAL TECHNIQUE; TARDIVE DYSKINESIA; TASTE DISORDER; THALAMOTOMY; THALAMUS; TREATMENT PLANNING; WEAKNESS; WEIGHT GAIN; WRIST;

EID: 33645820638     PISSN: 10928480     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11940-006-0016-8     Document Type: Review

References (63)

1. Lou JS, Jankovic J: Essential tremor: clinical correlates in 350 patients. Neurology 1991, 41:234-238.
2. Findley L: Tremors: differential diagnosis and pharmacology. In Parkinson's Disease and Movement Disorders. Edited by Jankovic J, Tolosa E. Baltimore, MD: Lippincott Williams and Wilkins; 1993:293-313.
3. Elble RJ, Higgins C, Hughes L: Longitudinal study of essential tremor. Neurology 1992, 42:441-443.
4. Hallet M, Dubinsky R. Glucose metabolism in the brain of patients with essential tremor. J Neurol Sciences 1993, 114:45-48.
5. Jenkins IH, Bain PG, Colebatch PD, et al.: A positron emission tomography study of essential tremor: evidence for overactivity of cerebellar connections. Ann Neurol 1993, 34:82-90.
6. Koller WC, Findley L: Tremor rating scale. In Handbook of Tremor Disorders. Edited by Findley L, Koller WC. New York: Marcel Dekker; 1995:1-5.
7. Bain PG, Findley LJ, Atchison P, et al.: Assessing tremor severity. J Neurol Neurosurg Psychiatry 1993, 56:868-873.
8. Zesiewicz TA, Elble R, Louis ED, et al.: Practice parameter: therapies for essential tremor: report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 2005, 64:2008-2020.
9. Koller WC, Biary N: Effect of alcohol on tremor: comparison with propranolol. Neurology 1984, 34:221-222.
10. Growdon JH, Shahani BT, Young RR: The effect of alcohol on essential tremor. Neurology 1975, 25:259-262.
11. Koller WC: Alcoholism in essential tremor. Neurology 1983, 33:1074-1076.
12. Miyoshi T, Kennedy WR, Yoon KS: Morphometric comparisons of capillaries in muscle spindles, nerve and muscle. Arch Neurol 1979, 36:547-552.
13. Abila B, Marshall RW, Wilson JF, et al.: Do beta-adreno-receptor blockers have peripheral or central effects in essential tremor? Brit J Clin Pharm 1983, 16:210.
14. Riley T, Pleet AB: Metoprolol tartrate for essential tremor. N Eng J Med 1979, 301:663.
15. Teravainen H, Larsen A, Fogelholm R. Comparison between the effects of pindolol and propranolol on essential tremor. Neurology 1977, 27:439-442.
16. Sevitt I: A comparison of propranolol and benzhexol in essential tremor. Practitioner 1974, 213:91-96.
17. Calzetti S, Perucca E: The pharmacological management of essential tremor. In Handbook of Tremor Disorders. Edited by Findley L, Koller WC. New York: Marcel Dekker; 1995:263-274.
18. Cleeves L, Findley L: Propranolol and propranolol-LA in essential tremor: a double blind comparative study. J Neurology Neurosurg Psychiatry 1988, 51:379-384.
19. Koller WC, Royse VL: Efficacy of primidone in essential tremor. Neurology 1986, 36:121-124.
20. Koller WC, Vetere-Overfield B: Acute and chronic effects of propranolol and primidone in essential tremor. Neurology 1989, 39:1587-1588.
21. Thompson C, Lang A, Parkes JD, et al.: A double blind trial of donazepam in essential benign tremor. Clin Neuroparmacol 1984, 7:83-88,
22. Huber SJ, Paulson GW: Efficacy of alprazolam for essential tremor. Neurology 1988, 38:241-243.
23. Kawasaki H, Tancredi V, D'Arcangelo G, et al.: Multiple actions of the novel anticonvulsant drug topiramate in the rat subiculum in vitro. Brain Res 1998, 807:125-134.
24. Connor GS: Topiramate as a novel treatment for essential tremor. Mov Disord 1999, 14:908.
25. Galvez-Jimemez N, Hargreave M: Topiramate and essential tremor. Ann Neurol 2000, 47:837-838.
26. Connor GS: A double-blind, placebo-controlled trial of topiramate treatment for essential tremor. Neurology 2002, 59:132-134.
27. Ondo WG, Jankovic J, Stacey M, et al.: Topiramate in essential tremor: a multicenter, double-blind, placebo-controlled trial. Neurology 2006, In press.
28. Gironell A, Kulisevsky J, Barbanoj M, et al.: A randomized placebo controlled comparative trial of gabapentin and propranolol in essential tremor. Arch Neurol 1999, 56:475-480.
29. Ondo WG, Hunter C, Schwartz K, et al.: High-dose gabapentin. for essential tremor: a double blind, placebo controlled, cross-over trial. Mov Disord 2000, 15:678-682.
30. Pahwa R, Lyons K, Hubble J, et al.: Double-blind controlled trial of gabapentin in essential tremor. Mov Disord 1998, 13:465-467.
31. Ondo WG, Jimenez JE, Vuong KD, et al.: An open-label pilot study of levetiracetarn for essential tremor. Clin Neuropharmacol 2004, 27:274-277.
32. Bushara KO, Malik T, Exconde RE: The effect of levetiracetam on essential tremor. Neurology 2005, 64:1078-1080.
33. Nakanishi I, Kohmoto J, Miwa H, et al.: Effectiveness of zonisamide on Parkinson's tremor: a pilot cross-over study in comparison with trixhexyphenidyl. Mov Disord 2004, 19(Suppl):S147.
34. Morita S, Miwa H, Kondo T: Effect of zonisamide on essential tremor. a pilot crossover study in comparison with arotinolol. Parkinsonism Relat Disord 2005, 11:101-103.
35. Biary N, Al Deeb S, Langenberg P:The effect of flunarizine on essential tremor. Neurology 1991, 41:311-312.
36. Curran T, Lang A: Flunarizine in essential tremor. Clin Neuropharmacol 1993, 16:460-463.
37. Garda-Ruiz PJ, Garcia de Yebenes Prous J, Jimenez-Jimenez J: Effect of nicardipine on essential tremor: brief report. Clin Neuropharmacol 1993, 16:456-459.
38. Jimenez-Jimenez J, Garcia-Ruiz PJ, Cabrera-Valdivia F: Nicardipine versus propranolol in essential tremor. Acta Neurologica 1994, 16:184-188.
39. Biary N, Bahou Y, Sofi MA, et al.: The effect of nimodipine on essential tremor: Neurology 1995, 45:1523-1525.
40. Bushara KO, Goldstein SR, Grimes GJ, et al.: Pilot trial of 1-octanol in essential tremor. Neurology 2004, 62:122-124.
41. Frucht SJ, Bordelon Y, Houghton VM, et al.: A pilot tolerability and efficacy trial of sodium oxybate in ethanol-responsive movement disorders. Mov Disord 2005, 20:1330-1337.
42. Muenter MD, Daube JR, Cavines JN, et al.: Treatment of essential tremor with methazolamide. Mayo Clin Proc 1991, 66:991-997.
43. Busenbark K, Pahwa R, Hubble J, et al.: Double-blind controlled study of methazolamide in the treatment of essential tremor. Neurology 1993, 43:1045-1047.
44. Pact V, Giduz T: Mirtazapine treats resting tremor, essential tremor, and Ievodopa induced dyskinesia. Neurology 1999, 53:1154.
45. Pahwa R, Lyons K: Mirtazapine in essential tremor: a double-blind, placebo-controlled pilot study. Mov Disord 2003, 18:584-587.
46. Mally J, Stone T: The effect of theophylline on essential tremor: the possible role of GABA. Pharmacol Biochem Behavior 1991, 39:345-349.
47. Mally J: Comparative study of theophylline and propranolol in essential tremor. Orvosi Hetilap 1992, 133:981-983.
48. Pakkenberg H, Pakkenberg B: Clozapine in the treatment of tremor. Acta Neurologica Scand 1986, 73:295-297.
49. McCarthy R: Clozapine reduces essential tremor independent of its antipsychotic effect: a case report. J Clin Psychopharmacol 1994, 14:212-213.
50. Sanson F, Schergna E, Semenzato D, et al.: Therapeutic effect of trazodone in the treatment of tremor. Multicentric double-blind study. Riv Neural 1986, 36:358-364.
51. Cleeves L, Findley LJ: Trazodone is ineffective in essential tremor. J Neural Neurosurg Psychiatry 1990, 53:268-269.
52. Koller WC, Herbster G, Cone S: Clonidine in the treatment of essential tremor. Mov Disord 1986, 1:235-237.
53. Brin MF, Lyons K Doucette J, et al.: A randomized, double masked, controlled trial of botulinum toxin type A in essential hand tremor. Neurology 2001, 56:1523-1528.
54. Pacchetti C, Mancini F, Bulgheroni M, et al.: Botulinum toxin treatment for functional disability ind,uced by essential tremor. Neurological Sci 2000, 21:349-353.
55. Wissel J, Masuhr F, Schelosky L, et al.: Quantitative assessment of botulinum toxin treatment in 43 patients with head tremor. Mov Disord 1997, 12:722-726.
56. Pahwa R, Busenbark K, Swanson-Hyland MA, et al.: Botulinum toxin treatment of essential head tremor. Neurology 1995, 45:822-824.
57. Adler CH, Bansberg SF, Hentz J, et al.: Botulinum toxin type A for treating voice tremor. Arch Neurol 2004, 61:1416-1420.
58. Ondo W, Almaguer M, Jankovic J et al.: Thalamic deep brain stimulation: comparison between unilateral and bilateral placement. Arch Neurol 2001, 58:218-222.
59. Limousin P, Speelman JD, Gielen F, et al.: Multicentre European study of thalamic stimulation in parkinsonian and essential tremor. J Neurol Neurosurg Psychiatr 1999, 66:289-296.
60. Caparros-Lefebvre D, Ruchoux MM, Blond S, et al.: Long term thalamic stimulation in Parkinson's disease: postmortem anatomodinical study. Neurology 1994, 44:1856-1860.
61. Koller WC, Lyons KE, Wilkinson SB, et al.: Long-term safety and efficacy of unilateral deep brain stimulation of the thalamus in essential tremor. Mov Disord 2001, 16:464-468.
62. Schuurman PR, Bosch DA, Bossuyt PM, et al.: A comparison of continuous thalamic stimulation and thalamotomy for suppression of severe tremor. N Engl J Med 2000, 342:461-468.
63. Young RF, Jacques S, Mark P, et al.: Gamma knife thalamotomy for treatment of tremor: long-term results. J Neurosurg 2000, 93(Suppl 3):128-135.